These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21603155)

  • 1. Management of the kidney transplant patient with chronic hepatitis C infection.
    Tang IY; Walzer N; Aggarwal N; Tzvetanov I; Cotler S; Benedetti E
    Int J Nephrol; 2011; 2011():245823. PubMed ID: 21603155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of viral hepatitis in solid organ transplantation].
    Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S
    Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of chronic viral hepatitis before and after renal transplantation.
    Gane E; Pilmore H
    Transplantation; 2002 Aug; 74(4):427-37. PubMed ID: 12352899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral hepatitis in solid organ transplantation other than liver.
    Vallet-Pichard A; Fontaine H; Mallet V; Pol S
    J Hepatol; 2011 Aug; 55(2):474-82. PubMed ID: 21241754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus and nonliver solid organ transplantation.
    Carbone M; Mutimer D; Neuberger J
    Transplantation; 2013 Mar; 95(6):779-86. PubMed ID: 23172130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
    Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
    Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of HCV infection in chronic kidney disease.
    Aoufi Rabih S; García Agudo R
    Nefrologia; 2011; 31(3):260-7. PubMed ID: 21407274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hepatitis C in patients with chronic kidney disease.
    Carvalho-Filho RJ; Feldner AC; Silva AE; Ferraz ML
    World J Gastroenterol; 2015 Jan; 21(2):408-22. PubMed ID: 25593456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients.
    Aljumah AA; Saeed MA; Al Flaiw AI; Al Traif IH; Al Alwan AM; Al Qurashi SH; Al Ghamdi GA; Al Hejaili FF; Al Balwi MA; Al Sayyari AA
    World J Gastroenterol; 2012 Jan; 18(1):55-63. PubMed ID: 22228971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation in the patient with hepatitis C.
    Domínguez-Gil B; Morales JM
    Transpl Int; 2009 Dec; 22(12):1117-31. PubMed ID: 19656350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation.
    Faisal N; Mumtaz K; Marquez M; Renner EL; Lilly LB
    Hepatol Int; 2015 Jan; 9(1):76-83. PubMed ID: 25788382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
    Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
    J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney Transplantation.
    Sasaki R; Kanda T; Yasui S; Haga Y; Nakamura M; Yamato M; Wu S; Nakamoto S; Arai M; Mikami S; Miyauchi H; Matsubara H; Yokosuka O
    Case Rep Gastroenterol; 2016; 10(2):248-56. PubMed ID: 27462193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C infection in hemodialysis patients: A review.
    Ozer Etik D; Ocal S; Boyacioglu AS
    World J Hepatol; 2015 Apr; 7(6):885-95. PubMed ID: 25937865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients.
    Muñoz De Bustillo E; Ibarrola C; Colina F; Castellano G; Fuertes A; Andrés A; Aguado JM; Rodicio JL; Morales JM
    J Am Soc Nephrol; 1998 Jun; 9(6):1109-13. PubMed ID: 9621297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.
    Dhanasekaran R; Sanchez W; Mounajjed T; Wiesner RH; Watt KD; Charlton MR
    Liver Int; 2015 Nov; 35(11):2433-41. PubMed ID: 26058570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hepatitis C in HIV infected and other immunocompromised individuals.
    Seth AK
    Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection and renal transplantation.
    Fabrizi F; Martin P; Ponticelli C
    Am J Kidney Dis; 2001 Nov; 38(5):919-34. PubMed ID: 11684543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.